Literature DB >> 16415431

Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx.

Ian Ganly1, Snehal G Patel, Jeannette Matsuo, Bhuvanesh Singh, Dennis H Kraus, Jay O Boyle, Richard J Wong, Ashok R Shaha, Nancy Lee, Jatin P Shah.   

Abstract

OBJECTIVE: To report the outcome of surgical salvage performed for early-stage squamous cell carcinoma of the glottic larynx that recurred or progressed after definitive radiotherapy.
DESIGN: Retrospective outcome analysis.
SETTING: Tertiary referral center specializing in head and neck cancer. PATIENTS: Forty-three patients who underwent salvage surgery after definitive radiation therapy for early-stage (T1-T2) glottic cancer were identified from a preexisting database of 662 patients with squamous cell carcinoma of the larynx treated at Memorial Sloan-Kettering Cancer Center between the years 1984 and 1998. The T stage at initial presentation was T1 in 20 (18%) and T2 in 23 (32%). Twenty-one patients (49%) were amenable to salvage partial laryngectomy (SPL), but 22 (51%) required salvage total laryngectomy (STL). Details on patient characteristics, tumor characteristics, postoperative complications, and survival outcome were extracted from the database. MAIN OUTCOME MEASURES: Overall survival, disease-specific survival, neck recurrence-free survival, and distant recurrence-free survival.
RESULTS: No postoperative death occurred following salvage surgery. The overall incidence of complications was 21%, with no difference between the SPL and STL groups. Patients who required STL had poorer overall survival and disease-specific survival compared with patients who required SPL (overall survival, 50% vs 89%; P = .003; disease-specific survival, 51% vs 93%; P = .002). This difference in survival was associated with a poorer neck recurrence-free survival and distant recurrence-free survival in the STL group compared with the SPL group (neck recurrence-free survival, 80% vs 100%; P = .04; distant recurrence-free survival, 71% vs 93%; P = .06). Univariate analysis showed that age and clinical T stage at recurrence were predictors of overall survival, disease-specific survival, and distant recurrence-free survival.
CONCLUSIONS: Careful selection of patients with early-stage glottic tumors that recur or progress after radiation allows patients to be successfully treated by partial laryngectomy with excellent survival outcome. However, despite an aggressive policy of performing partial laryngectomy when feasible, up to 50% of patients will require a total laryngectomy owing to progression of disease. These patients have poorer survival outcomes manifested by local, regional, and distant disease progression.

Entities:  

Mesh:

Year:  2006        PMID: 16415431     DOI: 10.1001/archotol.132.1.59

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  37 in total

1.  Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Authors:  Soon-Hyun Ahn; Hyun Jun Hong; Soon Young Kwon; Kee Hwan Kwon; Jong-Lyel Roh; Junsun Ryu; Jun Hee Park; Seung-Kuk Baek; Guk Haeng Lee; Sei Young Lee; Jin Choon Lee; Man Ki Chung; Young Hoon Joo; Yong Bae Ji; Jeong Hun Hah; Minsu Kwon; Young Min Park; Chang Myeon Song; Sung-Chan Shin; Chang Hwan Ryu; Doh Young Lee; Young Chan Lee; Jae Won Chang; Ha Min Jeong; Jae-Keun Cho; Wonjae Cha; Byung Joon Chun; Ik Joon Choi; Hyo Geun Choi; Kang Dae Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2017-01-03       Impact factor: 3.372

Review 2.  New biological markers in the decision of treatment of head and neck cancer patients.

Authors:  A Valenciano; L A Henríquez-Hernández; M Lloret; B Pinar; P C Lara
Journal:  Clin Transl Oncol       Date:  2014-07-01       Impact factor: 3.405

3.  Completion Total Laryngectomy Ten Years After Near Total Laryngectomy for Radiorecurrent Cancer of the Glottis.

Authors:  Bipin T Varghese; Shirish Patil
Journal:  Indian J Surg Oncol       Date:  2018-08-09

4.  Relationship between the time to locoregional recurrence and survival in laryngeal squamous-cell carcinoma.

Authors:  Philippe Gorphe; Yungan Tao; Pierre Blanchard; Caroline Even; Antoine Moya-Plana; Haïtham Mirghani; France Nguyen; Stéphane Temam; François Janot
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-02-09       Impact factor: 2.503

5.  Patterns of Care for Patients With Early-Stage Glottic Cancer Undergoing Definitive Radiation Therapy: A National Cancer Database Analysis.

Authors:  William A Stokes; Diana Abbott; Andy Phan; David Raben; Ryan M Lanning; Sana D Karam
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-04-06       Impact factor: 7.038

6.  [Surgical treatment options in laryngeal and hypopharyngeal cancer].

Authors:  Hans E Eckel; Ursula Schröder; Markus Jungehülsing; Orlando Guntinas-Lichius; Michael Markitz; Wolfgang Raunik
Journal:  Wien Med Wochenschr       Date:  2008

7.  Supracricoid partial laryngectomy with cricohyoidoepiglottopexy in patients with radiation therapy failure.

Authors:  Kuauhyama Luna-Ortiz; Philippe Pasche; Mario Tamez-Velarde; Veronica Villavicencio-Valencia
Journal:  World J Surg Oncol       Date:  2009-12-19       Impact factor: 2.754

8.  Methicillin Resistant Staphylococcus Aureus Infection as a causative agent of fistula formation following total laryngectomy for advanced head & neck cancer.

Authors:  Jean-Pierre Jeannon; Ahmad Orabi; Argyris Manganaris; Ricard Simo
Journal:  Head Neck Oncol       Date:  2010-06-28

9.  Conservative Curative Larynx Preserving Surgery for Subglottic Soft Tissue Recurrence Reinforced with Fascia-Lata and Strap Muscles.

Authors:  Dushyant Mandlik; Ashutosh Vatsyayan; Purvi Patel; Parin Patel; Kaustubh Patel
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-11-13

10.  Impact of Flap Reconstruction on Radiotoxicity After Salvage Surgery and Reirradiation for Recurrent Head and Neck Cancer.

Authors:  Allen S Ho; Zachary S Zumsteg; Annika Meyer; Nadeem Riaz; Rahmatullah Rahmati; Dennis H Kraus; Colleen McCarthy; Richard J Wong; Jatin P Shah; Nancy Y Lee
Journal:  Ann Surg Oncol       Date:  2016-08-09       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.